Advanced search
2 files | 1.46 MB Add to list

Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors

Author
Organization
Keywords
Phosphate bioisosteres, 5-Hydroxymethyl pyrimidines, MONOPHOSPHATE KINASE, DRUG DISCOVERY, IN-VITRO, ANALOGS, DNA, REDUCTION, DESIGN, Nucleoside analogues, Inhibitor, Thymidine monophosphate kinase, Mycobacterium tuberculosis

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 907.20 KB
  • Synthesis and Evaluation of 5 -Modified Thymidines and 5-Hydroxymethyl-2 -Deoxyuridines as M. tuberculosis Thymidylate Kinase Inhibitors.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 551.15 KB

Citation

Please use this url to cite or link to this publication:

MLA
Toti, Kiran, et al. “Synthesis and Evaluation of 5’-Modified Thymidines and 5-Hydroxymethyl-2’-Deoxyuridines as Mycobacterium Tuberculosis Thymidylate Kinase Inhibitors.” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 21, no. 1, 2013, pp. 257–68, doi:10.1016/j.bmc.2012.10.018.
APA
Toti, K., Verbeke, F., Risseeuw, M., Frecer, V., Munier-Lehmann, H., & Van Calenbergh, S. (2013). Synthesis and evaluation of 5’-modified thymidines and 5-hydroxymethyl-2’-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY, 21(1), 257–268. https://doi.org/10.1016/j.bmc.2012.10.018
Chicago author-date
Toti, Kiran, Frederick Verbeke, Martijn Risseeuw, Vladimir Frecer, Hélène Munier-Lehmann, and Serge Van Calenbergh. 2013. “Synthesis and Evaluation of 5’-Modified Thymidines and 5-Hydroxymethyl-2’-Deoxyuridines as Mycobacterium Tuberculosis Thymidylate Kinase Inhibitors.” BIOORGANIC & MEDICINAL CHEMISTRY 21 (1): 257–68. https://doi.org/10.1016/j.bmc.2012.10.018.
Chicago author-date (all authors)
Toti, Kiran, Frederick Verbeke, Martijn Risseeuw, Vladimir Frecer, Hélène Munier-Lehmann, and Serge Van Calenbergh. 2013. “Synthesis and Evaluation of 5’-Modified Thymidines and 5-Hydroxymethyl-2’-Deoxyuridines as Mycobacterium Tuberculosis Thymidylate Kinase Inhibitors.” BIOORGANIC & MEDICINAL CHEMISTRY 21 (1): 257–268. doi:10.1016/j.bmc.2012.10.018.
Vancouver
1.
Toti K, Verbeke F, Risseeuw M, Frecer V, Munier-Lehmann H, Van Calenbergh S. Synthesis and evaluation of 5’-modified thymidines and 5-hydroxymethyl-2’-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY. 2013;21(1):257–68.
IEEE
[1]
K. Toti, F. Verbeke, M. Risseeuw, V. Frecer, H. Munier-Lehmann, and S. Van Calenbergh, “Synthesis and evaluation of 5’-modified thymidines and 5-hydroxymethyl-2’-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 21, no. 1, pp. 257–268, 2013.
@article{3192256,
  author       = {{Toti, Kiran and Verbeke, Frederick and Risseeuw, Martijn and Frecer, Vladimir and Munier-Lehmann, Hélène and Van Calenbergh, Serge}},
  issn         = {{0968-0896}},
  journal      = {{BIOORGANIC & MEDICINAL CHEMISTRY}},
  keywords     = {{Phosphate bioisosteres,5-Hydroxymethyl pyrimidines,MONOPHOSPHATE KINASE,DRUG DISCOVERY,IN-VITRO,ANALOGS,DNA,REDUCTION,DESIGN,Nucleoside analogues,Inhibitor,Thymidine monophosphate kinase,Mycobacterium tuberculosis}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{257--268}},
  title        = {{Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors}},
  url          = {{http://doi.org/10.1016/j.bmc.2012.10.018}},
  volume       = {{21}},
  year         = {{2013}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: